Executive Summary
Ford's $19.5 billion writedown represents more than financial housekeeping—it signals a strategic retreat from EV ambitions that positions the company for regulatory tailwinds under Trump's loosened MPG rules. Bloomberg Intelligence identifies this as 'clearing the deck' behavior, where management absorbs maximum pain upfront to enable 2026 earnings recovery. The insider selling pattern (536,340 net shares sold, zero buys) suggests management lacks conviction in the turnaround timeline, creating a contrarian opportunity if execution succeeds. Simultaneously, BI's '50 Companies to Watch' research reveals a structural shift away from obvious AI plays toward infrastructure enablers—TSMC foundry capacity, Lam Research semiconductor equipment, and Constellation Energy's nuclear power for data centers. This represents variant perception: while markets chase LLMs and Nvidia, operators need picks-and-shovels infrastructure. Johnson & Johnson's Majestic 3 trial data showing 83% survival at 36 months versus 50% for existing treatments creates a massive competitive moat in multiple myeloma. The convergence of regulatory relief (Ford), corporate restructuring (Kraft Heinz CEO change), and breakthrough clinical data (J&J) suggests 2026 catalysts are underappreciated across multiple sectors.
Key Insights
what Tim Craighead said“Ford is taking 19.5 billion dollars in charges tied to an overhaul of its EV business... They've been losing around $25,000 on the EVD line per vehicle”
This is a preview. Log in to see the full analysis including investment opportunities, risks, catalysts, and detailed insights.